Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1563 of 6351
-
New peptide drug PQ203 enters human trials for Hard-to-Treat cancers
Disease control Recruiting nowThe primary purposes of this study are to determine the safety and tolerability of PQ203 in patients with advanced solid tumors including triple negative breast cancer (TNBC), and to determine a recommended Phase 2 dose level for future studies in TNBC.
Phase 1 • Sponsor: ProteinQure Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
AI stethoscope? new study uses smart tech to spot hidden heart danger
Diagnosis By invitation onlyThe DETECT-AS Diagnostic Study will assess the performance of artificial intelligence (AI) risk predictions to detect aortic stenosis using results from portable electrocardiogram (ECG) and cardiac ultrasound devices.
Sponsor: Yale University • Aim: Diagnosis
Last updated Jun 27, 2026 08:00 UTC
-
New drug avelumab aims to keep upper tract cancer at bay after chemo
Disease control Recruiting nowA Prospective Phase II Study of Adjuvant Cisplatin-Based Chemotherapy followed by Maintenance Avelumab in Upper Tract Urothelial Carcinoma
Phase 2 • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Could a zappy headband lift teen bipolar depression?
Symptom relief Recruiting nowThis randomized, double-blind, sham-controlled clinical trial aims to evaluate the efficacy and underlying biological mechanisms of HD-tDCS targeting the primary somatosensory cortex in adolescents with bipolar depression. Participants will be randomly assigned to receive either …
Sponsor: Jiangsu Province Nanjing Brain Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
New patch could ease agitation for Alzheimer's patients
Symptom relief Recruiting nowThe primary objective of this study is to evaluate the efficacy of DMTS on frequency and severity of agitation associated with dementia of the Alzheimer's type, compared with placebo.
Phase 2 • Sponsor: Teikoku Pharma USA, Inc. • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
New hope for Hard-to-Treat cancers: targeted drug enters human testing
Disease control Recruiting nowThis is an open-label, multi-center phase I clinical study to evaluate HRS-6093 Safety, Tolerability, and Pharmacokinetics in Participants harboring KRAS G12D Mutations with advanced solid tumors. The study consists of dose escalation, dose expansion and efficacy expansion.
Phase 1 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New light probe aims to prevent thyroid surgery complication
Disease control Recruiting nowThis is a prospective, single-blinded, randomized controlled trial to evaluate whether PTeye™ can reduce post-operative hypoparathyroidism (PH). The study will enroll consecutive patients undergoing total thyroidectomy in a teritary endocrine surgery unit in Hong Kong, randomizin…
Sponsor: The University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Could talking it out boost hearing aid success?
Symptom relief CompletedThe objective of the current research project is to investigate the effectiveness of communication training in first-time hearing aid users with mild to moderate hearing loss delivered in-person in groups or individually. In doing so, the project aims to strengthen evidence-based…
Sponsor: University Ghent • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
New spinal device offers hope for diabetic leg pain
Symptom relief By invitation onlyThis study is conducted to evaluate a new way of using spinal cord stimulation (SCS) in people with painful diabetic peripheral neuropathy (DPN). The device used is the Medtronic Inceptiv SCS, which is already approved by the U.S. FDA for treatment of chronic pain. In this study,…
Sponsor: TriCity Research Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
Houston program aims to break cycle of gun violence after injury
Disease control Recruiting nowA prior violent injury is one of the strongest predictors of future violent injury, highlighting the importance of effective hospital-based interventions to prevent reinjury. This project will establish and evaluate the Houston Hospital-Based Violence Intervention Program (Housto…
Sponsor: The University of Texas Health Science Center, Houston • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Could a drug for schizophrenia work differently in men and women?
Symptom relief Recruiting nowSchizophrenia differs between sexes in clinical symptoms and functional outcome. Negative symptoms are the core pathology of this disease. NMDA receptor (NMDAR) dysfunction is a key factor in negative symptoms. This study aims to examine the sex difference in the efficacy of an N…
Phase 2 • Sponsor: China Medical University Hospital • Aim: Symptom relief
Last updated Jun 26, 2026 18:32 UTC
-
HIV prevention shots coming to your local pharmacy?
Prevention OngoingThis is an open-label, single center study to evaluate implementation of a pharmacist-managed delivery of L4P in a community pharmacy setting and the impact of twice-yearly vs. quarterly PrEP visits on STI rates.
Phase 4 • Sponsor: Kelley-Ross & Associates, Inc. • Aim: Prevention
Last updated Jun 27, 2026 12:03 UTC
-
New drug duo takes on tough lung cancer
Disease control Recruiting nowThe primary objective for dose exploration and dose expansion is to evaluate the safety and tolerability of tarlatamab in combination with AB248. The primary objective for dose exploration only is to determine the recommended dose for expansion and/or maximum tolerated combinati…
Phase 1 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New pill targets hard-to-treat cancers with KRAS mutation
Disease control Recruiting nowThe goal of this trial is to learn if KQB548 works to treat patients with advanced solid malignancies with a KRAS G12D mutation. It will also learn about the safety of KQB548. The main questions it aims to answer are: * What is the safe dose of KQB548? * Does KQB548 decrease the…
Phase 1 • Sponsor: Kumquat Biosciences Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New hope for cancer patients: drug may fix Radiation-Related low platelets
Disease control Not yet recruitingWith the development of modern medicine, targeted and immunotherapies have been widely adopted in clinical practice. Beyond conventional chemotherapy combination regimens, the integration of radiotherapy into multimodal treatment strategies has also expanded significantly. While…
Phase 2 • Sponsor: Zhujiang Hospital • Aim: Disease control
Last updated Jun 26, 2026 14:03 UTC
-
Shock to the throat: new device helps stroke patients swallow
Symptom relief Recruiting nowA retrospective, open-label, matched-control registry study designed to characterize the effectiveness of Pharyngeal Electrical Stimulation (PES) to improve swallowing in patients with severe dysphagia post stroke when delivered using the Phagenyx® System in real-world clinical s…
Sponsor: Phagenesis Ltd. • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
Eye scans could spot hidden vision risk in down syndrome
Diagnosis CompletedThe initial purpose of the study is to determine the true tomographic based age-specific prevalence of keratoconus among Danish patients with Downs Syndrome. If, as expected, the prevalence is sizeable, the next step is to determine the optimal age for screening - considering bo…
Sponsor: University of Aarhus • Aim: Diagnosis
Last updated Sep 04, 2026 00:00 UTC
-
Can we predict who sleeps poorly after heart surgery?
Knowledge-focused CompletedSleep quality is a complex and multidimensional phenomenon shaped by the interaction of patient characteristics, symptom burden, and environmental factors specific to the intensive care unit environment. Despite this multidimensional nature, studies identifying predictors of slee…
Sponsor: Aydin Adnan Menderes University • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
New gene therapy CREPT-618 enters human trials for liver cancer
Disease control Recruiting nowThis is a single-center, open-label, dose-escalation Phase I clinical study designed to evaluate the safety (incidence of adverse events), maximum tolerated dose (MTD), optimal biological dose (OBD), and recommended Phase II dose (RP2D) of CREPT-618 in adult patients aged 18-75 w…
Phase 1 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Magnetic pulses could ease knee arthritis without drugs or surgery
Symptom relief Recruiting nowThis randomized, double-blind clinical trial aims to evaluate the effect of high-intensity pulsed electromagnetic field therapy (HI-PEMF) applied either exclusively on the knee joint or bimodally on the knee and quadriceps, in older adults with knee osteoarthritis. Both groups wi…
Sponsor: Hospital Civil de Guadalajara • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC